Drug Type Unknown |
Synonyms |
Target |
Mechanism EED inhibitors(Polycomb protein EED inhibitors), PDE9A inhibitors(Phosphodiesterase 9A inhibitors), PKR modulators(eukaryotic translation initiation factor 2 alpha kinase 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rare Diseases | Preclinical | CN | 12 Oct 2022 |